A novel Src homology 2 domain-containing molecule, Src-like adapter protein-2 (SLAP-2), which negatively regulates T cell receptor signaling

被引:33
作者
Pandey, A
Ibarrola, N
Kratchmarova, I
Fernandez, MM
Constantinescu, SN
Ohara, O
Sawasdikosol, S
Lodish, HF
Mann, M
机构
[1] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA
[3] Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense, Denmark
[4] Ludwig Inst Canc Res, B-1200 Brussels, Belgium
[5] Christian de Duve Inst Cellular Pathol, B-1200 Brussels, Belgium
[6] Kazusa DNA Res Inst, Chiba 2920812, Japan
[7] RIKEN Res Ctr Allergy & Immunol, Chiba 2920812, Japan
[8] NYU, Sch Med, Skirball Inst Biomed Res, New York, NY 10016 USA
关键词
D O I
10.1074/jbc.M110318200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have cloned a novel adapter protein containing Src homology 2 and Src homology 3 domains similar to the Src family of tyrosine kinases. This molecule lacks a catalytic tyrosine kinase domain and is related to a previously identified protein, Src-like adapter protein (SLAP), and is therefore designated SLAP-2. Northern blot analysis indicates that SLAP-2 is predominantly expressed in the immune system. Jurkat, T cells express SLAP-2 protein and overexpression of SLAP-2 in these cells negatively regulates T cell receptor signaling as assessed by interleukin-2 promoter or NF-AT promoter reporter constructs. Mutational analysis revealed that an intact SH2 domain of SLAP-2 is essential for this inhibitory effect, whereas mutation of the SH3 domain alone has no effect. This inhibitory effect is upstream of the activation of Ras and increase of intracellular calcium levels, as no inhibition was observed when the cells were activated by phorbol ester plus ionomycin. SLAP-2 interacts with Cbl in vivo in a phosphorylation independent manner and with ZAP-70 and T cell receptor chain upon T cell receptor activation. Finally, we show that the mutation of a predicted myristoylation site within the NH2-terminal of SLAP-2 is essential for its inhibitory effect. This report therefore implicates SLAP and SLAP-2 as a family of adapter proteins that negatively regulate T cell receptor signaling.
引用
收藏
页码:19131 / 19138
页数:8
相关论文
共 44 条
[1]   ACTIVATION OF P56LCK THROUGH MUTATION OF A REGULATORY CARBOXY-TERMINAL TYROSINE RESIDUE REQUIRES INTACT SITES OF AUTOPHOSPHORYLATION AND MYRISTYLATION [J].
ABRAHAM, N ;
VEILLETTE, A .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (10) :5197-5206
[2]   C-ELEGANS CELL-SIGNALING GENE SEM-5 ENCODES A PROTEIN WITH SH2 AND SH3 DOMAINS [J].
CLARK, SG ;
STERN, MJ ;
HORVITZ, HR .
NATURE, 1992, 356 (6367) :340-344
[3]   TRANSMEMBRANE SIGNALING BY ANTIGEN RECEPTORS OF B-LYMPHOCYTES AND T-LYMPHOCYTES [J].
DEFRANCO, AL .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (02) :163-175
[4]  
DONOVAN JA, 1994, J BIOL CHEM, V269, P22921
[5]   STRUCTURE OF THE REGULATORY DOMAINS OF THE SRC-FAMILY TYROSINE KINASE LCK [J].
ECK, MJ ;
ATWELL, SK ;
SHOELSON, SE ;
HARRISON, SC .
NATURE, 1994, 368 (6473) :764-769
[6]   Signal strength in thymic selection and lineage commitment [J].
Hogquist, KA .
CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (02) :225-231
[7]   Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signaling [J].
Holland, SJ ;
Liao, XC ;
Mendenhall, MK ;
Zhou, XL ;
Pardo, J ;
Chu, P ;
Spencer, C ;
Fu, A ;
Sheng, N ;
Yu, PW ;
Pali, E ;
Nagin, A ;
Shen, M ;
Yu, S ;
Chan, E ;
Wu, X ;
Li, C ;
Woisetschlager, M ;
Aversa, G ;
Kolbinger, F ;
Bennett, MK ;
Molineaux, S ;
Luo, Y ;
Payan, DG ;
Mancebo, HSY ;
Wu, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1263-1276
[8]   TRANSCRIPTIONAL REGULATION OF THE IL-2 GENE [J].
JAIN, J ;
LOH, C ;
RAO, A .
CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (03) :333-342
[9]   GENETIC AND BIOCHEMICAL-STUDIES OF PROTEIN N-MYRISTOYLATION [J].
JOHNSON, DR ;
BHATNAGAR, RS ;
KNOLL, LJ ;
GORDON, JI .
ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 :869-914
[10]   Signal transduction by the TCR for antigen [J].
Kane, LP ;
Lin, J ;
Weiss, A .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (03) :242-249